CytomX Appoints Alison Hannah Senior VP and Chief Medical Officer

Xconomy San Francisco — 

Alison Hannah has joined CytomX (NASDAQ: CTMX) as senior vice president and chief medical officer. Hannah was most recently a consultant to pharmaceutical and biotechnology companies. Her experience also includes positions at Sugen and Quintiles. South San Francisco-based CytomX is developing a type of cancer treatment it calls a “Probody drug.” The company’s pipeline includes wholly owned compounds, as well as programs in development under partnerships with Bristol-Myers Squibb (NYSE: BMY), AbbVie (NYSE: ABBV), and Amgen (NASDAQ: AMGN).